Bronchiolitis Associated with Mycoplasma pneumoniae Infection in Infants in Foshan China: An Epidemiologic Study

Cheng Chen1, Chunwang Lin1, Xiangming Zhong2

  • 1Department of Pediatric Respiratory, Shunde Women's and Children's Hospital of Guangdong Medical University, Foshan, Guangdong, China (mainland).

Insights

Mycoplasma pneumoniae (MP) is a significant cause of infant bronchiolitis, particularly in older infants (6-12 months). MP-associated bronchiolitis shows distinct patterns, including summer peaks and shorter hospital stays, with azithromycin aiding treatment.

Area of Science:

  • Pediatric Infectious Diseases
  • Respiratory Medicine
  • Microbiology

Background:

  • Bronchiolitis is a common infant respiratory illness, frequently caused by Respiratory Syncytial Virus (RSV).
  • The role of Mycoplasma pneumoniae (MP) in infant bronchiolitis etiology remains incompletely understood.
  • Understanding MP's contribution is crucial for accurate diagnosis and management of pediatric respiratory infections.

Purpose of the Study:

  • To investigate the clinical characteristics of Mycoplasma pneumoniae (MP)-associated bronchiolitis in infants.
  • To determine the epidemiological patterns and seasonal occurrence of MP in pediatric bronchiolitis.
  • To compare clinical features of MP-bronchiolitis with those of RSV-bronchiolitis.

Main Methods:

  • A retrospective study of 79 infants diagnosed with MP-bronchiolitis.
  • Inclusion criteria: infants admitted to specific hospitals between 2016-2018.
  • MP infection confirmed via serum immunoglobulin M detection.

Main Results:

  • MP detection rates increased annually from 2016 to 2018 (19.2% to 24.0%).
  • Peak MP infections occurred during June and July, primarily affecting infants aged 6-12 months.
  • MP-associated bronchiolitis patients were older and had shorter hospital stays compared to RSV cases (P<0.01 or P<0.05).

Conclusions:

  • Mycoplasma pneumoniae is a significant etiological agent in infant bronchiolitis, with a distinct summer seasonality.
  • Pulmonary interstitial infiltration is a characteristic finding in MP-associated bronchiolitis.
  • Azithromycin treatment can effectively shorten the duration of MP-associated bronchiolitis, aiding clinical management.